FDA seeks details on Shire/Noven ADHD patch
Shire and Noven Pharmaceuticals received an “approvable” letter from the FDA for their experimental attention deficit hyperactivity disorder (ADHD) patch, ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.